$ACTG

OCONNELL MAUREEN sold $152K of ACTG

OCONNELL MAUREEN sold 33,000 shares of ACACIA RESEARCH CORP (ACTG) at an average of $4.61 ($4.57–$4.63, $0.15M total) across 2 trades over 2026-09-02 to 2026-09-03.

Original reporting
SEC EDGAR · OCONNELL MAUREEN
Published Sep 4, 2026, 8:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 8:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACTG
Neutral
medium confidence
Mentioned
$ACTG
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACTGNeutralLow
01

Why it matters

The transaction is small and unlikely to move the stock, but it adds to the record of insider activity.

02

Market read

A routine insider sale with modest size; limited trading relevance.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 4/10Novelty 4/10Timing: filed today

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the sale.

Company-level read

Ticker impact

$ACTGNeutralMedium confidence
Context

Director Maureen O'Conell sold 33,000 shares for $152,042, reducing her stake to 254,655 shares.

Expected impact

Minimal short-term price pressure; likely no significant move.

Evidence & confidence

The sale represents only ~0.13% of the insider's post‑sale holdings and is under $200K, typical for liquidity needs.

Market effects

No broader sector impact; Acacia operates in diversified licensing.

Limited to US small‑cap investors.

Negligible

Counterpoint

The sale could be unrelated to confidence; directors often sell for personal liquidity.

Key entities

  • Acacia Research Corp

    US-listed diversified licensing company (ticker ACTG).

  • Maureen O'Conell

    Director of Acacia Research Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACTGMedAI 8/10

Acacia Research (ACTG) Q2 2026 Earnings Call Transcript

Acacia Research (ACTG) reported Q2 2026 revenue of $114.6 million, up from $51.2 million a year earlier, mainly from a $60.9 million IP licensing settlement with TP-Link. Adjusted diluted EPS was $0.13. GAAP net income was $47,000, including a $30.9 million noncash impairment tied to Life Sciences holdings. Cash and liquidity were $334.6 million.